Status:
SUSPENDED
Vitamin D and Type 2 Diabetes Risk in UK Adults
Lead Sponsor:
Liverpool Hope University
Conditions:
Overweight
Obesity
Eligibility:
All Genders
18-50 years
Brief Summary
This study is exploring the association between vitamin D and Type 2 diabetes risk in normal weight and overweight UK adults.
Detailed Description
The aim of this study is to assess the link between vitamin D status and glucose homeostasis in a population of normal weight and overweight individuals (BMI\> 18.5 Kg/m2).
Eligibility Criteria
Inclusion
- Normal weight and overweight and obese adults (BMI\>= 18.5 Kg/m2) with no restriction to ethnicity, occupation or socioeconomic status.
- Males and females
- 18-50 years
Exclusion
- Patients diagnosed with diabetes type 2, myocardial infarction or coronary heart disease.
- HbA1c \> 6.4%
- Pregnancy
- Diagnosis of liver disease (including liver enzymes \> 3 times above normal values)
- Diagnosis of renal disease (creatinine of \> 150 mmol/l)
- Post-menopausal women
Key Trial Info
Start Date :
July 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2022
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04339530
Start Date
July 1 2019
End Date
July 1 2022
Last Update
May 10 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
School of Health sciences
Liverpool, United Kingdom, L1 9JD